5/2
07:52 pm
vrtx
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know [Yahoo! Finance]
5/1
10:26 am
vrtx
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
4/30
09:23 am
vrtx
American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day [Yahoo! Finance]
Low
Report
American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day [Yahoo! Finance]
4/29
11:54 am
vrtx
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]
4/28
08:54 am
vrtx
2 Top Growth Stocks to Buy Right Now and Hold Forever [Yahoo! Finance]
Low
Report
2 Top Growth Stocks to Buy Right Now and Hold Forever [Yahoo! Finance]
4/26
01:20 pm
vrtx
Pioneer Institute study finds IRA discourages non-opioid drug innovation [Yahoo! Finance]
Low
Report
Pioneer Institute study finds IRA discourages non-opioid drug innovation [Yahoo! Finance]
4/26
11:55 am
vrtx
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older [Yahoo! Finance]
Low
Report
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older [Yahoo! Finance]
4/26
11:43 am
vrtx
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
Low
Report
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
4/26
07:07 am
vrtx
The Americas’ Fastest Growing Companies [FT.com - Mergermarket]
Low
Report
The Americas’ Fastest Growing Companies [FT.com - Mergermarket]
4/26
05:13 am
vrtx
The Americas’ Fastest Growing Companies [Financial Times (FT.com) (UK)]
Low
Report
The Americas’ Fastest Growing Companies [Financial Times (FT.com) (UK)]
4/26
05:06 am
vrtx
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis [Financial Times (FT.com) (UK)]
Low
Report
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis [Financial Times (FT.com) (UK)]
4/25
07:49 pm
vrtx
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]
4/25
09:55 am
vrtx
2 Fantastic Growth Stocks to Buy Right Now [Yahoo! Finance]
Low
Report
2 Fantastic Growth Stocks to Buy Right Now [Yahoo! Finance]
4/25
09:42 am
vrtx
Walgreens expands specialty pharmacy with unit dedicated to cell and gene therapies [Seeking Alpha]
Low
Report
Walgreens expands specialty pharmacy with unit dedicated to cell and gene therapies [Seeking Alpha]
4/23
10:06 am
vrtx
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies [Yahoo! Finance]
Low
Report
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies [Yahoo! Finance]
4/23
09:17 am
vrtx
Vertex in-licenses cell therapy technology for diabetes candidates [Seeking Alpha]
Low
Report
Vertex in-licenses cell therapy technology for diabetes candidates [Seeking Alpha]
4/23
07:37 am
vrtx
Global Vaccine Contract Manufacturing Market Trends Analysis Report 2024-2030: Capacity Expansion by Contract Manufacturers, & Vaccination Innovation and Robust Vaccine Pipeline Bolsters Growth [Yahoo! Finance]
Low
Report
Global Vaccine Contract Manufacturing Market Trends Analysis Report 2024-2030: Capacity Expansion by Contract Manufacturers, & Vaccination Innovation and Robust Vaccine Pipeline Bolsters Growth [Yahoo! Finance]
4/23
06:26 am
vrtx
Arcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic Fibrosis [Seeking Alpha]
Low
Report
Arcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic Fibrosis [Seeking Alpha]
4/23
05:54 am
vrtx
U.S. Gene Therapy Market Size, Share & Trends Analysis Report 2024-2030: Robust Pipeline and Growing Prevalence of Target Diseases Fueling Growth and Developments [Yahoo! Finance]
Low
Report
U.S. Gene Therapy Market Size, Share & Trends Analysis Report 2024-2030: Robust Pipeline and Growing Prevalence of Target Diseases Fueling Growth and Developments [Yahoo! Finance]
4/23
03:45 am
vrtx
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
Low
Report
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
4/23
12:55 am
vrtx
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES [Yahoo! Finance]
Low
Report
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES [Yahoo! Finance]
4/23
12:45 am
vrtx
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
Low
Report
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
4/23
12:45 am
vrtx
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
Low
Report
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
4/23
12:45 am
vrtx
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
Low
Report
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
4/22
07:27 am
vrtx
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today [Yahoo! Finance]
Low
Report
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today [Yahoo! Finance]